DOSSIER · 13F-HR · Q4 2025

BOONE CAPITAL MANAGEMENT LLC

$319M in tracked AUM across 15 positions as of Q4 2025.

BC
CIK 0001882053 · last filed Dec 31, 2025
Total AUM
$319M
as of Q4 2025
Holdings
15
positions
Whale Score
62
62
tracked
Activity
no data
changes this Q
AI Analysis · Q4 2025
Comprehensive Analysis of Boone Capital Management LLC (SEC 13F)
1. Portfolio Overview

Boone Capital Management LLC reported a significant portfolio contraction for the quarter ended September 30, 2025. The total portfolio value decreased by 16.7%, falling from $233.19 million to $194.26 million. This decline in asset value is likely attributable to a combination of market performance in the healthcare sector and substantial capital reallocation, as evidenced by the high volume of trading ...

The portfolio is highly concentrated, comprising only 12 holdings. This low number of positions indicates a conviction-based strategy rather than a broad market indexing approach. Despite the reduction in total assets, the fund remains focused on specific mid-to-large cap equities, with a clear preference for the healthcare and life sciences industries. The lack of "Increased Stakes" in the current quarter suggests the manager is not currently doubling down on existing winners but is rather actively rotating into new ideas.

2. Key Holdings

The portfolio is anchored by Medtronic PLC (MDT), which occupies the top position with a value of $40.84 million, representing 21.02% of the total portfolio. This is a notable outlier, as it is the only position to exceed 20% of the portfolio's weight, suggesting a defensive "core" holding or a significant bet on the medical device sector.

Quarter at a glance — Q4 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q4 2025.

#HoldingValueSharesWeight
01
G5960L103
MEDTRONIC PLC
$41M429K12.9%
02
MIRM
MIRUM PHARMACEUTICALS INC
$33M421K10.4%
03
IONS
IONIS PHARMACEUTICALS INC
$33M418K10.4%
04
CI
THE CIGNA GROUP
$27M96K8.3%
05
BMRN
BIOMARIN PHARMACEUTICAL INC
$24M412K7.7%
06
NBIX
NEUROCRINE BIOSCIENCES INC
$22M152K6.8%
07
UNH
UNITEDHEALTH GROUP INC
$20M62K6.4%
08
AZN
ASTRAZENECA PLC
$20M220K6.4%
09
HQY
HEALTHEQUITY INC
$19M213K6.1%
10
G5509L101
LIVANOVA PLC
$18M289K5.6%

Filing history

2025Q4Dec 31
$319M 64.0%
15 positionsView →
2025Q3Sep 30
$194M 16.7%
12 positionsView →
2025Q2Jun 30
$233M 20.6%
11 positionsLocked
2025Q1Mar 31
$294M 0.9%
12 positionsLocked
2024Q4Dec 31
$296M 23.2%
13 positionsLocked
2024Q3Sep 30
$386M 0.6%
17 positionsLocked
2024Q2Jun 30
$383M 22.5%
19 positionsLocked
2024Q1Mar 31
$494M 15.4%
21 positionsLocked
2023Q4Dec 31
$428M 35.2%
21 positionsLocked
2023Q3Sep 30
$317M 13.8%
13 positionsLocked
2023Q2Jun 30
$279M 30.4%
13 positionsLocked
2023Q1Mar 31
$214M 9.6%
12 positionsLocked
Showing 12 of 13